Atea Pharmaceuticals, Inc. Increase (Decrease) in Contract with Customer, Liability
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2023-02-28
- Atea Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2021-12-31 was -$192.18M.
- Atea Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2021-09-30 was -$32.81M.
- Atea Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2021-06-30 was -$10.39M.
- Atea Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2021-03-31 was -$65.98M.
- Atea Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for fiscal 2021 was -$301.37M, a 200.00% decline from fiscal 2020.
- Atea Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for fiscal 2020 was $301.37M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$192.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$224.99M derived: sum of 2 quarters · filed 2023-02-28 | -$235.38M derived: sum of 3 quarters · filed 2023-02-28 | -$301.37M 10-K · filed 2023-02-28 |
| 2021-09-30 | -$32.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$43.20M derived: sum of 2 quarters · filed 2022-11-07 | -$109.19M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | -$10.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$76.38M 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | -$65.98M 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $301.37M 10-K · filed 2023-02-28 |